1. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by bromergocryptine;Besser, G.M.; Parke, L.; Edwards, C.R.W.; Forsyth, I.A.; McNeilly, A.S.;Br Med J,1972
2. Inhibition of prolactin release in vitro and;Schally, A.V.; Arimura, A.; Takahara, J.; Redding, T.W.; Dupont, A.,1974
3. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function;Scanlon, M.F.; Rodriguez-Arnao, D.D.; McGregor, A.M.;Clin Endocrinol (Oxf,1981
4. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma;Quigley, M.E.; Judd, S.J.; Gilliland, G.B.; Yen, S.S.C.;J Clin Endocrinol Metab,1980
5. Hypothalamic-pituitary regulation of prolactin secreting microadenomas;Jaquet, P.; Guibot, M.; Lucioni, J.; Grisoli, F.;Ann Intern Med; prolactin physiology and pathology,1978